Pr Pharma Engineers Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 31-07-2024
- Paid Up Capital ₹ 8.00 Cr
as on 31-07-2024
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.54 Cr
as on 31-07-2024
- Revenue 46.87%
(FY 2023)
- Profit 88.05%
(FY 2023)
- Ebitda 91.05%
(FY 2023)
- Net Worth 35.46%
(FY 2023)
- Total Assets 129.65%
(FY 2023)
About Pr Pharma Engineers
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 8.00 Cr.
The company currently has active open charges totaling ₹20.54 Cr.
Pulla Koppula and Sailaja Koppula serve as directors at the Company.
- CIN/LLPIN
U29100TG2019PTC133117
- Company No.
133117
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jun 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Pr Pharma Engineers?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pulla Koppula  | Managing Director | 03-Jun-2019 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sailaja Koppula | Director | 03-Jun-2019 | Current |
Financial Performance of Pr Pharma Engineers.
Pr Pharma Engineers Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 46.87% increase. The company also saw a substantial improvement in profitability, with a 88.05% increase in profit. The company's net worth Soared by an impressive increase of 35.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pr Pharma Engineers?
In 2022, Pr Pharma Engineers had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Radiant Pr Airtech Private LimitedActive 3 years 4 monthsPulla Koppula and Sailaja Koppula are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 16 Jan 2020 | ₹20.54 Cr | Open |
How Many Employees Work at Pr Pharma Engineers?
Pr Pharma Engineers has a workforce of 262 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pr Pharma Engineers, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pr Pharma Engineers's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
